Search results for " Age Factors"

showing 10 items of 55 documents

Prognostic factors of survival in patients with advanced cancer admitted to home care

2011

Abstract CONTEXT: Data regarding prognostication of life expectancy in patients with advanced cancer are of paramount importance to patients, families, and clinicians. However, data regarding patients followed at home are lacking. OBJECTIVES: The aim of this study was to evaluate the correlation between various factors recorded at the beginning of home care assistance and survival. METHODS: A sample of consecutive patients admitted to two home care programs was surveyed. A preliminary consensus was achieved as to the possible variables easy to be recorded at home. These included age at the time of home care admission, gender, residence, marital status, primary cancer diagnosis, Karnofsky Pe…

Malemedicine.medical_specialtyPalliative careMEDLINEContext (language use)advanced cancer; Home care; prognosis; survival; Age Factors; Aged; Aged 80 and over; Dyspnea; Fatigue; Female; Humans; Male; Middle Aged; Neoplasms; Palliative Care; Prognosis; Quality of Life; Sex Factors; Survival Rate; Home Care Services; Anesthesiology and Pain Medicine; Neurology (clinical); Nursing (all)2901 Nursing (miscellaneous)Prognostic survival factorSettore MED/42 - Igiene Generale E ApplicatasurvivalHome careadvanced cancer patientSex FactorsQuality of lifeNeoplasms80 and overadvanced cancerHumansMedicineSurvival rateFatigueNursing (all)2901 Nursing (miscellaneous)General NursingAgedAged 80 and overbusiness.industryPalliative CareAge FactorsPrognostic survival factors; advanced cancer patients; home careMiddle AgedPrognosisHome Care ServicesSurvival RateDyspneaAnesthesiology and Pain MedicineBlood pressureEmergency medicineQuality of LifeLife expectancyPhysical therapyMarital statusFemaleNeurology (clinical)business
researchProduct

The frequency of alcoholism in patients with advanced cancer admitted to an acute palliative care unit and a home care program

2015

Abstract Context Cancer patients with a history of alcoholism may be problematic. The frequency of alcoholism among patients with advanced cancer has never been reported in Italy or other European countries. Objectives The aim of this prospective study was to determine the frequency of alcoholism, assessed with a simple and validated instrument, among patients with advanced cancer who were referred to two different palliative care settings: an acute inpatient palliative care unit (PCU) of a comprehensive cancer center in a metropolitan area and a home care program (HCP) in a territorial district, localized in the mountains of Italy. Methods A consecutive sample of patients admitted to an in…

Malemedicine.medical_specialtyPediatricsPalliative careContext (language use)advanced cancer patientsNursingCancer Care Facilitiesadvanced cancer patients; Alcoholism; CAGE; palliative care; Anesthesiology and Pain Medicine; NursingSettore MED/42 - Igiene Generale E ApplicataInterviews as Topicadvanced cancer patientSex FactorsNeoplasmsSurveys and QuestionnairesmedicineHumansIn patientProspective StudiesKarnofsky Performance StatusPsychiatryProspective cohort studyGeneral NursingNursing (all)2901 Nursing (miscellaneous)Agedpalliative carePerformance statusbusiness.industryMedicine (all)Age FactorsCanceradvanced cancer patients; Alcoholism; CAGE; palliative care; Age Factors; Aged; Alcoholism; Female; Humans; Interviews as Topic; Italy; Karnofsky Performance Status; Male; Middle Aged; Neoplasms; Palliative Care; Prospective Studies; Sex Factors; Surveys and Questionnaires; Cancer Care Facilities; Home Care Services; Anesthesiology and Pain Medicine; Neurology (clinical); Nursing (all)2901 Nursing (miscellaneous); Medicine (all)Cancer Care FacilitiesMiddle Agedmedicine.diseaseHome Care ServicesAlcoholismAnesthesiology and Pain MedicineItalyCAGEFemaleNeurology (clinical)Care programbusiness
researchProduct

Splenic marginal zone lymphoma: A prognostic model for clinical use

2006

The Integruppo Italiano Linfomi (IIL) carried out a study to assess the outcomes of splenic marginal zone lymphoma and to identify prognostic factors in 309 patients. The 5-year cause-specific survival (CSS) rate was 76%. In univariate analysis, the parameters predictive of shorter CSS were hemoglobin levels below 12 g/dL (P < .001), albumin levels below 3.5 g/dL (P = .001), International Prognostic Index (IPI) scores of 2 to 3 (P < .001), lactate dehydrogenase (LDH) levels above normal (P < .001), age older than 60 years (P = .01), platelet counts below 100 000/μL (P = .04), HbsAg-positivity (P = .01), and no splenectomy at diagnosis (P = .006). Values that maintained a negative influence …

Malesplenic marginal zone lymphoma; prognostic factors; International Prognostic Index (IPI)VILLOUS LYMPHOCYTESHydro-LyaseB-CELLLongitudinal StudiePredictive Value of TestInternational Prognostic Index (IPI)BiochemistryGastroenterologyHemoglobinschemistry.chemical_compoundInternational Prognostic IndexRisk FactorsBONE-MARROW INFILTRATION; NON-HODGKINS-LYMPHOMA; C VIRUS-INFECTION; VILLOUS LYMPHOCYTES; B-CELLBONE-MARROW INFILTRATIONAge FactorLongitudinal StudiesMultivariate AnalysiAged 80 and overUnivariate analysisHematologyMortality rateAge FactorsHematologyMiddle AgedPrognosisSplenic NeoplasmSurvival RatePredictive value of testsHumanAdultmedicine.medical_specialtyLymphoma B-CellPrognosiImmunologysplenic marginal zone lymphomaDisease-Free SurvivalPredictive Value of TestsAlbuminsInternal medicineLactate dehydrogenaseAdult; Age Factors; Aged; Aged 80 and over; Albumins; Disease-Free Survival; Hemoglobins; Humans; Hydro-Lyases; Longitudinal Studies; Lymphoma B-Cell; Male; Middle Aged; Multivariate Analysis; Platelet Count; Predictive Value of Tests; Prognosis; Risk Factors; Splenic Neoplasms; Survival Rate; Models Theoretical; HematologymedicineHumansHemoglobinNON-HODGKINS-LYMPHOMASplenic marginal zone lymphomaSurvival rateHydro-LyasesAgedPlatelet Countbusiness.industrySplenic NeoplasmsAlbuminRisk Factorprognostic factorsCell BiologyModels Theoreticalmedicine.diseaseSurgerychemistryMultivariate AnalysisbusinessC VIRUS-INFECTION
researchProduct

A time series study on the effects of heat on mortality and evaluation of heterogeneity into European and Eastern-Southern Mediterranean cities: resu…

2013

Background: The Mediterranean region is particularly vulnerable to the effect of summer temperature. Within the CIRCE project this time-series study aims to quantify for the first time the effect of summer temperature in Eastern-Southern Mediterranean cities and compared it with European cities around the Mediterranean basin, evaluating city characteristics that explain between-city heterogeneity. Methods: The city-specific effect of maximum apparent temperature (Tappmax) was assessed by Generalized Estimation Equations, assuming a linear threshold model. Then, city-specific estimates were included in a random effect meta-regression analysis to investigate the effect modification by several…

Mediterranean climateMaleMESH: Urban HealthHot TemperatureTime FactorsClimateHealth Toxicology and MutagenesisVulnerability010501 environmental sciences01 natural sciencesMediterranean BasinMESH: Regression AnalysisMESH: Cause of Death0302 clinical medicineAfrica NorthernMESH: ChildCause of Death11. Sustainability030212 general & internal medicineMediterranean regionSocioeconomicsChildMESH: Aged[SDV.EE]Life Sciences [q-bio]/Ecology environmentMiddle EastMESH: Middle AgedMESH: Infant Newborn1. No povertyAge FactorsMiddle AgedMESH: ClimateMESH: Middle East/epidemiologyMESH: Infant3. Good healthGeographyMESH: Young AdultChild Preschool8. Economic growthRegression AnalysisFemaleSeasonsAdultmedicine.medical_specialtyAdolescentClimate changeHeat Stress DisordersMESH: Mediterranean Region/epidemiology03 medical and health sciencesMiddle EastYoung AdultmedicineMESH: CitiesHumansCitiesMortalityMESH: Heat Stress Disorders/mortality*0105 earth and related environmental sciencesMESH: Hot Temperature/adverse effectsAgedEstimationMESH: AdolescentMESH: Age FactorsMESH: Heat Stress Disorders/etiologyMESH: HumansPublic healthResearchMESH: Child PreschoolMESH: Time FactorsInfant NewbornUrban HealthPublic Health Environmental and Occupational HealthMESH: Africa Northern/epidemiologyInfantMESH: AdultMESH: MaleApparent temperature13. Climate actionHot temperature; Mortality; Mediterranean region; Heterogeneity; Age groups; Public Health; TIME series analysis; Older people; Public health; Unemployment statistics; Climatic changes[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieMESH: Mortality/trends*HeterogeneityAge groupsMESH: FemaleMESH: SeasonsMedicine; Geriatrics
researchProduct

Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with adv…

2012

Purpose The combination of pertuzumab and trastuzumab resulted in a clinical benefit rate (CBR) of 50% in patients with human epidermal growth factor receptor 2 (HER2) –positive breast cancer whose disease progressed during prior trastuzumab-based therapy. To define whether this previously observed encouraging activity was a result of the combination of pertuzumab and trastuzumab or of pertuzumab alone, we recruited a third cohort of patients who received pertuzumab without trastuzumab. We then investigated the impact of reintroducing trastuzumab to patients whose disease progressed on pertuzumab monotherapy. Patients and Methods Twenty-nine patients with HER2-positive breast cancer whose d…

OncologyCancer ResearchReceptor ErbB-2MESH: Risk AssessmentMESH: Dose-Response Relationship Drug0302 clinical medicineTrastuzumabAntineoplastic Combined Chemotherapy ProtocolsMedicineProspective StudiesProspective cohort studyskin and connective tissue diseasespertuzumab; trastuzumab; breast cancerMESH: Treatment OutcomeMESH: Aged0303 health sciencesMESH: Middle AgedMESH: ErythrocytesAge FactorsMESH: Maximum Tolerated DoseMESH: Neoplasm StagingMiddle AgedPrognosis3. Good healthtrastuzumabMESH: Antineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeOncologyTolerabilityMESH: Receptor erbB-2030220 oncology & carcinogenesisMESH: Survival AnalysisDisease Progression[SDV.IMM]Life Sciences [q-bio]/ImmunologyMESH: Disease ProgressionFemalePertuzumabmedicine.drugAdultmedicine.medical_specialty[SDV.IMM] Life Sciences [q-bio]/ImmunologyMaximum Tolerated DoseMESH: Blood TransfusionBreast NeoplasmsMESH: Drug Administration ScheduleAntibodies Monoclonal HumanizedLoading doseMESH: Cell SeparationRisk AssessmentMESH: PrognosisDisease-Free SurvivalDrug Administration Schedule03 medical and health sciencesbreast cancerBreast cancerMESH: PrionspertuzumabInternal medicineHumansMESH: Patient SelectionNeoplasm InvasivenessneoplasmsSurvival analysis030304 developmental biologyAgedNeoplasm StagingMESH: Age FactorsMESH: HumansDose-Response Relationship Drugbusiness.industryPatient SelectionMESH: AdultMESH: Neoplasm InvasivenessMESH: Creutzfeldt-Jakob SyndromeTrastuzumabmedicine.diseaseSurvival AnalysisMESH: Prospective StudiesMESH: Antibodies Monoclonal HumanizedMESH: Disease-Free SurvivalbusinessMESH: FemaleProgressive diseaseMESH: Breast NeoplasmsJournal of clinical oncology : official journal of the American Society of Clinical Oncology
researchProduct

Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of …

2011

Purpose The purpose of this study was to develop accurate models and nomograms to predict local recurrence, distant metastases, and survival for patients with locally advanced rectal cancer treated with long-course chemoradiotherapy (CRT) followed by surgery and to allow for a selection of patients who may benefit most from postoperative adjuvant chemotherapy and close follow-up. Patients and Methods All data (N = 2,795) from five major European clinical trials for rectal cancer were pooled and used to perform an extensive survival analysis and to develop multivariate nomograms based on Cox regression. Data from one trial was used as an external validation set. The variables used in the ana…

OncologyMaleCancer ResearchColorectal cancerMESH : AgedKaplan-Meier EstimateMESH : Randomized Controlled Trials as Topiclaw.invention[ SDV.CAN ] Life Sciences [q-bio]/Cancer0302 clinical medicineRandomized controlled triallawMESH : FemaleStage (cooking)Neoplasm MetastasisMESH: Models TheoreticalMESH : Rectal NeoplasmsSettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIARandomized Controlled Trials as TopicMESH: Aged0303 health sciencesMESH: Middle AgedMESH : Neoplasm Recurrence LocalAge FactorsMiddle AgedMESH : Adult3. Good healthEuropeOncology030220 oncology & carcinogenesisMESH : Neoplasm MetastasisFemaleMESH: Neoplasm Recurrence LocalAdultmedicine.medical_specialtyMESH : Sex FactorsMESH : MaleMESH : Europe[SDV.CAN]Life Sciences [q-bio]/CancerMESH : Kaplan-Meier Estimate03 medical and health sciencesRECTAL CANCERSex FactorsMESH: Sex FactorsInternal medicinemedicineHumansMESH : Middle AgedSurvival analysisMESH: Kaplan-Meier Estimate030304 developmental biologyAgedMESH: Age FactorsMESH: HumansProportional hazards modelbusiness.industryRectal NeoplasmsMESH : Models TheoreticalMESH : HumansMESH: Rectal NeoplasmsMESH: AdultNomogramModels Theoreticalmedicine.diseaseMESH: Neoplasm MetastasisMESH: MaleSurgeryClinical trialMESH: Randomized Controlled Trials as TopicMESH : Age FactorsMESH: EuropeNeoplasm Recurrence LocalbusinessMESH: FemaleChemoradiotherapy
researchProduct

Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and met…

2021

BACKGROUND The long-term risk for major bleeding in patients receiving extended (beyond the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous thromboembolism (VTE) is uncertain. PURPOSE To determine the incidence of major bleeding during extended anticoagulation of up to 5 years among patients with a first unprovoked VTE, overall, and in clinically important subgroups. DATA SOURCES MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials from inception to 23 July 2021. STUDY SELECTION Randomized controlled trials (RCTs) and prospective cohort studies reporting major bleeding among patients with a first unprovoked VTE who were to receive oral anticoagu…

Oralmedicine.medical_specialtymedicine.drug_classAdministration OralHemorrhage030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawRisk FactorsInternal medicineInternal MedicineMedicineHumansCumulative incidenceAge Factor030212 general & internal medicineProspective cohort study610 Medicine &amp; healthAdministration Oral Age Factors Aged Anticoagulants Hemorrhage Humans Middle Aged Risk Factors Venous ThromboembolismAgedbusiness.industryIncidence (epidemiology)Risk FactorAnticoagulantAge FactorsAnticoagulantsGeneral MedicineVenous ThromboembolismVitamin K antagonistMiddle Aged3. Good healthConcomitantMeta-analysisAdministrationAdministration Oral; Age Factors; Aged; Anticoagulants; Hemorrhage; Humans; Middle Aged; Risk Factors; Venous ThromboembolismbusinessCohort studyHuman
researchProduct

Benign myoclonic epilepsy in infancy followed by childhood absence epilepsy

2011

Abstract Benign myoclonic epilepsy in infancy (BMEI) is a rare syndrome included among idiopathic generalized epilepsies (IGE) and syndromes with age-related onset. Recently, it has been shown that a few patients with BMEI later had other epilepsy types mainly IGE but never childhood absence epilepsy (CAE). We report a patient who at 11 months of age showed isolated myoclonic jerks occurring several times a day. The ictal video-EEG and polygraphic recording revealed generalized discharge of spike-wave (SW) lasting 1–2s associated with isolated bilateral synchronous jerk involving mainly the upper limbs controlled by valproic acid (VPA). At 6 years and 8 months the child developed a new elec…

Pediatricsmedicine.medical_specialtyMyoclonic JerkClinical NeurologyEpilepsies MyoclonicEpilepsiesChildhood absence epilepsyEpilepsyChildhood absence epilepsyEpilepsy in infancySettore M-PSI/08 - Psicologia ClinicaHumansMedicineRare syndromeIctalMyoclonic epilepsy Epilepsy in infancy Idiopathic epilepsy Childhood absence epilepsyChildValproic AcidEpilepsybusiness.industryIdiopathic epilepsyAge FactorsIctal eegGeneral Medicinemedicine.diseaseChildhood absence epilepsy; Epilepsy in infancy; Idiopathic epilepsy; Myoclonic epilepsy; Age Factors; Child; Epilepsies Myoclonic; Epilepsy Absence; Female; HumansSettore MED/39 - Neuropsichiatria InfantileAbsenceEpilepsy AbsenceNeurologyAnesthesiaMyoclonic epilepsyMyoclonic epilepsyFemaleNeurology (clinical)Myoclonicbusinessmedicine.drugSeizure
researchProduct

Cognitive impairment and stroke in elderly patients.

2016

Daniele Lo Coco,1 Gianluca Lopez,1 Salvatore Corrao,2,31Neurology and Stroke Unit, 2Department of Internal Medicine, National Relevance and High Specialization Hospital Trust ARNAS Civico, Di Cristina, Benfratelli, Palermo, 3Centre of Research for Effectiveness and Appropriateness in Medicine (C.R.E.A.M.), Di.Bi.M.I.S., University of Palermo, Palermo, Italy Abstract: We reviewed current knowledge about the interaction between stroke and vascular risk factors and the development of cognitive impairment and dementia. Stroke is increasingly recognized as an important cause of cognitive problems and has been implicated in the development of both Alzheimer&#39;s disease and vascular dementia. Th…

Preventive Health ServiceGerontologylcsh:Diseases of the circulatory (Cardiovascular) systemAgingEndocrinology Diabetes and MetabolismDiseaseReview0302 clinical medicineCognitionRisk FactorsPreventive Health ServicesPrevalenceMedicineAge FactorPharmacology (medical)030212 general & internal medicineCognitive declineStrokeAged 80 and overAge FactorsCognitionHematologyGeneral MedicinePrognosiscerebrovascular diseaseStrokeCardiology and Cardiovascular MedicineRisk assessmentHumanPrognosielderlyRisk AssessmentVascular risk factorAging; Cerebrovascular disease; Cognitive function; Dementia; Vascular risk factors; Age Factors; Aged; Aged 80 and over; Aging; Cognition Disorders; Geriatric Assessment; Humans; Prevalence; Preventive Health Services; Prognosis; Quality of Life; Risk Assessment; Risk Factors; Stroke; Cognition; Cardiology and Cardiovascular Medicine; Pharmacology (medical); Public Health Environmental and Occupational Health; Hematology; Endocrinology Diabetes and MetabolismCognition Disorder03 medical and health sciencesDementiaHumansCognitive rehabilitation therapyVascular dementiaGeriatric Assessmentcognitive functioncognitive impairmentAgedbusiness.industryRisk FactorPublic Health Environmental and Occupational Healthmedicine.diseaselcsh:RC666-701vascular risk factorsQuality of LifebusinessCognition Disorders030217 neurology & neurosurgerydementiaVascular health and risk management
researchProduct

Prenatal tobacco smoke exposure increases hospitalizations for bronchiolitis in infants

2015

Background Tobacco smoke exposure (TSE) is a worldwide health problem and it is considered a risk factor for pregnant women’s and children’s health, particularly for respiratory morbidity during the first year of life. Few significant birth cohort studies on the effect of prenatal TSE via passive and active maternal smoking on the development of severe bronchiolitis in early childhood have been carried out worldwide. Methods From November 2009 to December 2012, newborns born at ≥33 weeks of gestational age (wGA) were recruited in a longitudinal multi-center cohort study in Italy to investigate the effects of prenatal and postnatal TSE, among other risk factors, on bronchiolitis hospitalizat…

Pulmonary and Respiratory MedicineAdultmedicine.medical_specialtyPediatricsTime FactorsTime FactorOffspringLongitudinal StudieRisk AssessmentTobacco smoke exposure Pregnancy Infant Bronchiolitis Hospitalization Risk factorBronchiolitis; Hospitalization; Infant; Pregnancy; Risk factor; Tobacco smoke exposure; Adult; Age Factors; Bronchiolitis; Female; Humans; Infant; Infant Newborn; Inhalation Exposure; Italy; Longitudinal Studies; Maternal Exposure; Pregnancy; Risk Assessment; Risk Factors; Smoking; Time Factors; Tobacco Smoke Pollution; Hospitalization; Prenatal Exposure Delayed Effects; Pulmonary and Respiratory MedicineRisk FactorsPregnancymedicineHumansAge FactorLongitudinal StudiesBronchiolitiRisk factorIntensive care medicineInhalation exposurePregnancyInhalation Exposurebusiness.industryResearchSmokingAge FactorsInfant NewbornGestational ageInfantNewbornmedicine.diseaseHospitalizationItalyBronchiolitisMaternal ExposureTobacco smoke exposurePrenatal Exposure Delayed EffectsBronchiolitisFemaleTobacco Smoke PollutionRisk factorRisk assessmentbusinessHumanCohort study
researchProduct